Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

PREPARE

8. Laboratory Research

Meet our Laboratory Research Core team

Last updated on 16 October 2026

The PREPARE Laboratory Research Core (Core 2) aims to grow and sustain key laboratory capabilities and resources to support and accelerate pandemic research in Singapore and the region.

Lead

Image of Dr Conrad Chan

Dr Conrad Chan is the Lead of the Laboratory Research Core. He is also the Deputy Lead of the Vaccines & Therapeutics Co-operative, and a Senior Principal Scientific Officer (PREPARE Laboratory) in CDA with a background in virology and immunology. He did his PhD in Immunology at National University of Singapore on the development of therapeutic monoclonal antibodies against viral pathogens. His research interests are in high containment laboratories, humoral immunity and serology, vaccine and therapeutic testing/evaluation and viral characterization and biobanking.

Key personnel

Profile picture of Ng Yan Ling

Dr Ng Yan Ling is a Senior Scientific Officer in the PREPARE Laboratory Research Core, Singapore.  She leads the in vitro team to develop protocols for and conduct viral isolation, culture, inactivation and antiviral testing in a high containment (BSL-3) environment. She also coordinates multiple research projects across PREPARE’s network of local and international collaborators to ensure that her team’s work can support Singapore’s research into pandemic disease threats.

Profile picture of Fakhriedzwan

Dr Fakhriedzwan Fitri Haji Idris is a Senior Scientific Officer at the in the PREPARE Laboratory Research Core, Singapore, where he leads the in vivo research team in a high containment (BSL-3) environment. In this role, he oversees the preclinical evaluation of vaccines and therapeutics targeting high-priority epidemic and pandemic pathogens, supporting multiple PREPARE collaborative projects and ensuring compliance with biosafety and IACUC ethical standards.

Our strategy

  • Sustain a dedicated BSL2+/3 laboratory and team trained to support pandemic research in high containment, including in vitro and in vivo studies, viral isolation and characterization and clinical sample processing and analysis

  • Develop key research support capabilities together with the relevant co-ops and external partners

  • Sustain the microbiology platform to produce reference material for diagnostic development together with Diagnostic Co-op

  • Establish a regional biobanking network op for rapid outbreak response together with Regional Network Co-op

  • Build recombinant virus and respiratory tissue platforms for translational research together with Vaccines & Therapeutics Co-op

  • Set up a forward deployment team and collaboration strategy to accelerate outbreak research regionally

Our collaborations

We work with both local and overseas non-profits, government agencies, research institutes and private enterprise to co-create capabilities for pandemic readiness.